Skip to content

Sterile Compounding: Parenteral Nutrition CSPS-2020 Update

Hospital and home care based pharmacists often compound parenteral nutrition (PN) solutions for their patients. The Massachusetts Board of Pharmacy requires that pharmacists engaged in sterile products compounding obtain additional education specific to this area in order to maintain their licensure. This course will provide specific information for the safe compounding of parenteral nutrition solutions, considered one the most complex types of parenteral admixtures that most pharmacists who do sterile products compounding will encounter, and how the revised USP 797 regulations will impact PN compounding

This module (2.0 CE), along with the other three MCPHS sterile compounding CE modules, ‘History and Basics - Aseptic Technique USP 797, 2019/20' (1.5 CE), ‘What’s the Hazard? USP 800 Review’ (1.0 CE), and ‘503b Outsourcing Facilities, Hospital Pharmacist Intro' (0.5 CE), total to 5.0 credits of sterile compounding.

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Discuss the safety issues associated with the parenteral nutrition (PN) compounding process
  • Describe how knowledge deficits can lead to PN compounding errors
  • List the factors that can lead to calcium-phosphate precipitation in a PN solution
  • Understand where errors occur depending upon the method of PN compounding used


Kathleen M. Gura, PharmD, BCNSP, FASHP, FPPAG, FASPEN
Kathy Gura is the Clinical Research Program Manager and a clinical pharmacist with the Clinical Nutrition Service in the Division of Gastroenterology, Hepatology, and Nutrition at Boston Children's Hospital. She is also an Assistant Professor of Pediatrics at Harvard Medical School and Associate Professor of Pharmacy Practice at the MCPHS University in Boston. Certified as a Nutritional Support Pharmacist, Dr. Gura is a Fellow of ASPEN ASHP and, the Pediatric Pharmacy Advocacy Group. She is the recipient of numerous awards including the 2012 Distinguished Pharmacist award from the American Society for Parenteral and Enteral Nutrition and the 2008 ASPEN Serlick Award for safe practice in the field of parenteral nutrition. In 2009 she was awarded Drug Therapy Research Award by the American Society of Health Systems Pharmacists for her work involving IV lipid emulsions. She has served on several expert committees involved with USP 797 and USP 799. Kathy has authored over 150 peer-reviewed publications and book chapters. Her research was funded by the March of Dimes and the FDA’s Orphan Drug Development Program which led to the approval of Omegaven in July 2018.


ACPE logo

Release Date: September 24, 2019
Expiration Date: September 27, 2021
Contact Hours: 2.0
Universal Activity Number: 0026-0000-19-008-H03-P
ACPE Topic Designator: Law

MA licensed pharmacists, please refer to MA BOP policy 2018-03 section VI for further information on the use CE credits designated for pharmacy law (03) and compounding (07) to meet annual licensure requirements. Pharmacists licensed outside of MA should refer to their own state boards of Pharmacy for more information.

Registration Fee: Free to MCPHS Alumni and full-time employees; $12.00 for all other professionals.